Prescription and over-the-counter medication recalls
Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.
4,474 stored notices, reported between Jun 20, 2012 and Sep 9, 2026. Newest first.
Reported Feb 22, 2017
Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Actavis Inc.
FDA (openFDA drug enforcement)
Reported Feb 22, 2017
Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Aurobindo Pharma USA Inc.
FDA (openFDA drug enforcement)
Reported Feb 22, 2017
SLIMFIT X capsules, packaged in a 60-cont bottle
High riskUsing this product could cause serious injury, illness or death — stop using it now.Jersey Shore Supplements, LLC
FDA (openFDA drug enforcement)
Reported Feb 22, 2017
Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Leo Pharma Inc.
FDA (openFDA drug enforcement)
Reported Feb 22, 2017
MegaJex Herbal Supplement, Maximum Formula for Men, Fast acting, Increase Stamina, 20 capsules, MS Bionics, Gardena, CA
High riskUsing this product could cause serious injury, illness or death — stop using it now.MS Bionic
FDA (openFDA drug enforcement)
Reported Feb 22, 2017
Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Teva Pharmaceuticals USA
FDA (openFDA drug enforcement)
Reported Feb 15, 2017
Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9;…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Apotex Inc.
FDA (openFDA drug enforcement)
Reported Feb 15, 2017
Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Aurobindo Pharma USA Inc.
FDA (openFDA drug enforcement)
Reported Feb 15, 2017
Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Dr. Reddy's Laboratories, Inc.
FDA (openFDA drug enforcement)
Reported Feb 15, 2017
Potassium Chloride Oral Solution, USP, 10%, 20 mEq per 15 mL, packaged in 15 mL unit dose cups (NDC 66689-047-01), 50…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.VistaPharm, Inc.
FDA (openFDA drug enforcement)
Reported Feb 8, 2017
Flucanozole Tablets, USP, 50 mg, a) 30 count (NDC 55111-143-30) and b) 100 count (NDC 55111-143-01) bottles, Rx Only,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Dr. Reddy's Laboratories, Inc.
3 more products in this recall
FDA (openFDA drug enforcement)
Reported Feb 8, 2017
Endure 400 Scrub-Stat (chlorhexidine gluconate) Foam Forming Solution, 4%, packaged in plastic (HDPE) bottles,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Ecolab, Inc.
FDA (openFDA drug enforcement)
Reported Feb 8, 2017
MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Fresenius Kabi USA, LLC
FDA (openFDA drug enforcement)
Reported Feb 8, 2017
Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Hetero Drugs Ltd. - Unit 1
FDA (openFDA drug enforcement)
Reported Feb 8, 2017
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Sun Pharmaceutical Industries, Inc.
FDA (openFDA drug enforcement)
Reported Feb 8, 2017
Nystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDC 66689-008-02), b) 16…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.VistaPharm, Inc.
10 more products in this recall
FDA (openFDA drug enforcement)
Reported Feb 1, 2017
Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Actavis Inc.
FDA (openFDA drug enforcement)
Reported Feb 1, 2017
Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in double lined PE liners inside…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Cambrex Charles City Inc.
FDA (openFDA drug enforcement)
Reported Feb 1, 2017
Temozolomide Capsules, 100 mg, packaged in a) 5-count bottles (NDC 0378-5262-98), b) 14-count bottles (NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Mylan LLC.
3 more products in this recall
FDA (openFDA drug enforcement)
Reported Feb 1, 2017
Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Roxane Laboratories, Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Feb 1, 2017
buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88)…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Sun Pharmaceutical Industries, Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Feb 1, 2017
Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Teva Pharmaceuticals USA
FDA (openFDA drug enforcement)
Reported Feb 1, 2017
DEXAMETHASONE ELIXIR, USP, 0.5 mg/5 mL, 8 fl.oz., Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals
FDA (openFDA drug enforcement)
Reported Jan 25, 2017
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g tubes, Rx Only, Manufactured by Perrigo, Yeruham, Israel,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.L. Perrigo Company
FDA (openFDA drug enforcement)
Free recall alerts
Get alerted about new Medication recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.
Related categories
RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.